Evidence map›Paper›PMID 34302733›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting.

Alexander W Kay, Micaela Sandoval, Godwin Mtetwa, Musa Mkhabela, Banele Ndlovu, Tara Devezin, Welile Sikhondze, Debrah Vambe, Joyce Sibanda, Gloria S Dube and 3 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Tuberculosis Infection in Children and Adolescents.Pathogens (Basel, Switzerland) · 2022
    Review
  14. Tuberculosis care models for children and adolescents: a scoping review.Bulletin of the World Health Organization · 2022
    Article
  15. Review
  16. Article
  17. Clinical standards for the diagnosis, treatment and prevention of TB infection.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2022
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alexander W KayThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.ORCID 0000-0001-5283-4697
Micaela SandovalThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Godwin MtetwaBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini.
Musa MkhabelaBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini.
Banele NdlovuBaylor College of Medicine Children's Foundation-Eswatini, Mbabane, Eswatini.
Tara DevezinThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Welile SikhondzeEswatini National Tuberculosis Control Program, Manzini, Eswatini.
Debrah VambeEswatini National Tuberculosis Control Program, Manzini, Eswatini.
Joyce SibandaEswatini National Tuberculosis Control Program, Manzini, Eswatini.
Gloria S DubeEswatini National Tuberculosis Control Program, Manzini, Eswatini.
Robert H StevensIndependent Consultant to StopTB Partnership, Geneva, Switzerland.
Bhekumusa LukheleThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Anna M MandalakasThe Global Tuberculosis Program, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

Funding

Developing Clinical Prediction Tools to Define Strategies for Differentiated Service Delivery in Children and Adolescents Living with HIV in sub-Saharan Africa.K01TW011482 · FIC · BAYLOR COLLEGE OF MEDICINE · PI KAY, ALEXANDER WILLIAM · 2020 to 2024
$749k
FIC NIH HHS K01 TW011482
6 · The paper itself

Abstract

backgroundThe prevention of tuberculosis (TB) in child contacts of TB cases and people living with human immunodeficiency virus (HIV) is a public health priority, but global access to TB preventive therapy (TPT) remains low. In 2019, we implemented Vikela Ekhaya, a novel community-based TB contact management program in Eswatini designed to reduce barriers to accessing TPT.

methodsVikela Ekhaya offered differentiated TB and HIV testing for household contacts of TB cases by using mobile contact management teams to screen contacts, assess their TPT eligibility, and initiate and monitor TPT adherence in participants' homes.

resultsIn total, 945 contacts from 244 households were screened for TB symptoms; 72 (8%) contacts reported TB symptoms, and 5 contacts (0.5%) were diagnosed with prevalent TB. A total of 322 of 330 (98%) eligible asymptomatic household contacts initiated TPT. Of 322 contacts initiating TPT, 248 children initiated 3 months of isoniazid and rifampicin and 74 children and adults living with HIV initiated 6 months of isoniazid; 298 (93%) completed TPT. In clustered logistic regression analyses, unknown HIV status (adjusted odds ratio [aOR] 5.7, P = .023), positive HIV status (aOR 21.1, P = .001), urban setting (aOR 5.6, P = .006), and low income (aOR 5.9, P = .001) predicted loss from the cascade of care among TPT-eligible contacts.

conclusionVikela Ekhaya demonstrated that community-based TB household contact management is a feasible, acceptable, and successful strategy for TB screening and TPT delivery. The results of this study support the development of novel, differentiated, community-based interventions for TB prevention and control.

Indexed as

HIV InfectionsTuberculosisAdultChildContact TracingHumansIsoniazidLevonorgestrelRifampinIsoniazidLevonorgestrelRifampincontact tracingglobal healthHIVprevention and controltuberculosis

Identifiers

PMID34302733
PMCPMC9070808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.